Treatment of cancer stem cells from human colon adenocarcinoma cell line HT-29 with resveratrol and sulindac induced mesenchymal-endothelial transition rate. [electronic resource]
Producer: 20190816Description: 377-388 p. digitalISSN:- 1432-0878
- Antigens, CD -- metabolism
- Antineoplastic Agents -- pharmacology
- Autophagy -- drug effects
- Cadherins -- metabolism
- Cell Differentiation -- drug effects
- Chitinase-3-Like Protein 1 -- metabolism
- Epithelial-Mesenchymal Transition -- drug effects
- HT29 Cells
- Humans
- N-Acetylgalactosaminyltransferases -- metabolism
- Neoplastic Stem Cells -- drug effects
- Resveratrol -- pharmacology
- Signal Transduction -- drug effects
- Sulindac -- pharmacology
- Wnt3A Protein -- antagonists & inhibitors
- von Willebrand Factor -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.